Qube Research & Technologies LTD Enochian Biosciences Inc Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	N/A	-24,055 Reduced 35.39%	43,923 $202,000
Q4 2023 Feb 13, 2024	BUY	$4.3 - $4.7 $253,962 - $277,586	59,061 Added 662.34%	67,978 $312,000
Q3 2023 Nov 13, 2023	SELL	$0.0 - $4.46 $0 - $90,618	-20,318 Reduced 69.5%	8,917 $39,000
Q2 2023 Aug 14, 2023	BUY	$0.4 - $1.3 $11,694 - $38,005	29,235 New	29,235 $16,000
Q2 2022 Aug 15, 2022	SELL	$1.93 - $8.73 $39,429 - $178,353	-20,430 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$4.42 - $9.0 $39,284 - $79,992	8,888 Added 77.01%	20,430 $169,000
Q4 2021 Feb 01, 2022	BUY	$6.71 - $12.55 $77,446 - $144,852	11,542 New	11,542 $84,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.